Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9ANW3
Term | Name | Level | Count |
---|---|---|---|
GO:0006414 | translational elongation | 5 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003746 | translation elongation factor activity | 4 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0008135 | translation factor activity, RNA binding | 3 | 3 |
GO:0045182 | translation regulator activity | 1 | 3 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 113 | 117 | PF00656 | 0.475 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.737 |
CLV_NRD_NRD_1 | 354 | 356 | PF00675 | 0.387 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.737 |
CLV_PCSK_SKI1_1 | 131 | 135 | PF00082 | 0.514 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 16 | 20 | PF00082 | 0.281 |
CLV_PCSK_SKI1_1 | 328 | 332 | PF00082 | 0.266 |
CLV_PCSK_SKI1_1 | 343 | 347 | PF00082 | 0.308 |
DEG_APCC_DBOX_1 | 295 | 303 | PF00400 | 0.538 |
DEG_SCF_FBW7_1 | 271 | 278 | PF00400 | 0.658 |
DOC_CYCLIN_RxL_1 | 228 | 241 | PF00134 | 0.541 |
DOC_CYCLIN_yCln2_LP_2 | 346 | 352 | PF00134 | 0.475 |
DOC_MAPK_gen_1 | 228 | 238 | PF00069 | 0.543 |
DOC_MAPK_gen_1 | 340 | 350 | PF00069 | 0.508 |
DOC_MAPK_gen_1 | 355 | 362 | PF00069 | 0.322 |
DOC_MAPK_MEF2A_6 | 343 | 350 | PF00069 | 0.471 |
DOC_MAPK_MEF2A_6 | 355 | 362 | PF00069 | 0.340 |
DOC_MAPK_MEF2A_6 | 76 | 84 | PF00069 | 0.530 |
DOC_MAPK_NFAT4_5 | 343 | 351 | PF00069 | 0.500 |
DOC_MAPK_NFAT4_5 | 355 | 363 | PF00069 | 0.465 |
DOC_MIT_MIM_1 | 157 | 167 | PF04212 | 0.364 |
DOC_PP1_RVXF_1 | 123 | 129 | PF00149 | 0.410 |
DOC_PP1_RVXF_1 | 231 | 238 | PF00149 | 0.406 |
DOC_PP2B_LxvP_1 | 346 | 349 | PF13499 | 0.457 |
DOC_USP7_MATH_1 | 255 | 259 | PF00917 | 0.701 |
DOC_USP7_MATH_1 | 262 | 266 | PF00917 | 0.642 |
DOC_USP7_MATH_1 | 275 | 279 | PF00917 | 0.572 |
DOC_WW_Pin1_4 | 271 | 276 | PF00397 | 0.624 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.394 |
LIG_14-3-3_CanoR_1 | 183 | 193 | PF00244 | 0.696 |
LIG_14-3-3_CanoR_1 | 208 | 213 | PF00244 | 0.529 |
LIG_14-3-3_CanoR_1 | 276 | 280 | PF00244 | 0.648 |
LIG_14-3-3_CanoR_1 | 284 | 288 | PF00244 | 0.624 |
LIG_Actin_WH2_2 | 152 | 169 | PF00022 | 0.437 |
LIG_Actin_WH2_2 | 314 | 330 | PF00022 | 0.575 |
LIG_deltaCOP1_diTrp_1 | 116 | 121 | PF00928 | 0.328 |
LIG_eIF4E_1 | 13 | 19 | PF01652 | 0.362 |
LIG_eIF4E_1 | 341 | 347 | PF01652 | 0.524 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.451 |
LIG_FHA_2 | 111 | 117 | PF00498 | 0.407 |
LIG_FHA_2 | 185 | 191 | PF00498 | 0.625 |
LIG_FHA_2 | 239 | 245 | PF00498 | 0.560 |
LIG_FHA_2 | 306 | 312 | PF00498 | 0.451 |
LIG_GBD_Chelix_1 | 215 | 223 | PF00786 | 0.368 |
LIG_LIR_Gen_1 | 116 | 126 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 116 | 121 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 338 | 342 | PF02991 | 0.513 |
LIG_LRP6_Inhibitor_1 | 358 | 364 | PF00058 | 0.445 |
LIG_Rb_LxCxE_1 | 317 | 338 | PF01857 | 0.501 |
LIG_SH2_CRK | 23 | 27 | PF00017 | 0.468 |
LIG_SH2_CRK | 342 | 346 | PF00017 | 0.540 |
LIG_SH2_NCK_1 | 213 | 217 | PF00017 | 0.574 |
LIG_SH2_STAP1 | 129 | 133 | PF00017 | 0.460 |
LIG_SH2_STAT3 | 129 | 132 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.362 |
LIG_SH2_STAT5 | 165 | 168 | PF00017 | 0.505 |
LIG_SH2_STAT5 | 63 | 66 | PF00017 | 0.281 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.281 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.676 |
LIG_SUMO_SIM_anti_2 | 77 | 83 | PF11976 | 0.531 |
LIG_SUMO_SIM_par_1 | 80 | 85 | PF11976 | 0.499 |
LIG_TRAF2_1 | 187 | 190 | PF00917 | 0.577 |
LIG_UBA3_1 | 235 | 240 | PF00899 | 0.545 |
MOD_CDK_SPK_2 | 271 | 276 | PF00069 | 0.624 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.545 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.595 |
MOD_CK1_1 | 265 | 271 | PF00069 | 0.640 |
MOD_CK1_1 | 282 | 288 | PF00069 | 0.673 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.564 |
MOD_CK2_1 | 105 | 111 | PF00069 | 0.380 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.575 |
MOD_CK2_1 | 238 | 244 | PF00069 | 0.522 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.539 |
MOD_GlcNHglycan | 271 | 274 | PF01048 | 0.594 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.547 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.448 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.674 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.499 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.549 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.540 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.682 |
MOD_GSK3_1 | 265 | 272 | PF00069 | 0.610 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.594 |
MOD_N-GLC_1 | 38 | 43 | PF02516 | 0.319 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.370 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.497 |
MOD_NEK2_1 | 269 | 274 | PF00069 | 0.710 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.489 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.281 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.494 |
MOD_PIKK_1 | 110 | 116 | PF00454 | 0.419 |
MOD_PK_1 | 208 | 214 | PF00069 | 0.586 |
MOD_PKA_1 | 239 | 245 | PF00069 | 0.589 |
MOD_PKA_1 | 260 | 266 | PF00069 | 0.730 |
MOD_PKA_2 | 201 | 207 | PF00069 | 0.538 |
MOD_PKA_2 | 260 | 266 | PF00069 | 0.664 |
MOD_PKA_2 | 275 | 281 | PF00069 | 0.542 |
MOD_PKA_2 | 283 | 289 | PF00069 | 0.649 |
MOD_Plk_1 | 110 | 116 | PF00069 | 0.476 |
MOD_Plk_2-3 | 38 | 44 | PF00069 | 0.413 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.350 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.474 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.406 |
MOD_Plk_4 | 208 | 214 | PF00069 | 0.563 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.694 |
MOD_Plk_4 | 289 | 295 | PF00069 | 0.646 |
MOD_Plk_4 | 341 | 347 | PF00069 | 0.500 |
MOD_ProDKin_1 | 271 | 277 | PF00069 | 0.624 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.394 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.413 |
TRG_ENDOCYTIC_2 | 342 | 345 | PF00928 | 0.474 |
TRG_ER_diArg_1 | 161 | 163 | PF00400 | 0.517 |
TRG_ER_diArg_1 | 219 | 222 | PF00400 | 0.615 |
TRG_ER_diArg_1 | 260 | 262 | PF00400 | 0.737 |
TRG_Pf-PMV_PEXEL_1 | 171 | 175 | PF00026 | 0.520 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HY02 | Leptomonas seymouri | 68% | 98% |
A0A1X0NNU8 | Trypanosomatidae | 36% | 91% |
A0A3R7MZA1 | Trypanosoma rangeli | 37% | 100% |
A0A3S7WRV8 | Leishmania donovani | 94% | 99% |
A4H6V1 | Leishmania braziliensis | 83% | 100% |
C9ZQA1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9AGC3 | Leishmania infantum | 94% | 99% |
Q4QGQ7 | Leishmania major | 93% | 100% |
V5DE18 | Trypanosoma cruzi | 39% | 100% |